Please login to the form below

Not currently logged in
Email:
Password:

Astronauts to trial healthcare wearables in space

Canadian Space Agency plans to test a 'smart shirt' in an upcoming mission
Carré Technologies Astroskin

A 'smart shirt' designed to remotely monitor the wearer's health via a series of sensors is set to be tested in space in an upcoming mission by the Canadian Space Agency (CSA).

It has signed a $2.4m deal with Carré Technologies that will see the wearable sensors developer's bio-monitoring system taken aboard the International Space Station (ISS) by Canadian astronaut David Saint-Jacques during a six-month mission in 2018-2019.

The wearable tech - called Astroskin - collects scientific data on activity levels, sleep quality and vital signs, including blood oxygen levels, blood pressure, heart rate and electrical activity, and breathing rate.

Pierre-Alexandre Fournier, co-founder and chief executive of Carré Technologies, said: “Deploying our wearable sensors and software to the ISS is significant as this represents the ultimate remote patient monitoring scenario.

“The findings tracking the health of astronauts will be used to make our healthcare system more accessible and support new home care and telemedicine services.”

The Astroskin developers already have an eye on the technology's future in cardiology and sleep treatment, and hope to use data collected from the ISS trial to help bring the product to market for health monitoring in hard-to-reach patients worldwide.

Canadian minister for transport Marc Garneau said: “Astroskin may have many applications on Earth, such as medical monitoring of those confined to their homes by illness, people living in remote areas with limited medical access, and those working in hazardous environments.

“It is another in a long list of space technologies brought down to Earth for all of us.”

Article by
Rebecca Clifford

24th October 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

14_ipad_lowres.jpg
Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...
How Transparent Is Transparency?
The second annual publication of transfer of value (TOV) data has just been publically disclosed. For those of you that it passed by, it seems to have generated very little...
Geraldine Murphy
LEO: Patients benefit from transparency
Paving the way for openness in pharma...

Infographics